You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Cubist to pay up to $1.6b for two drug makers

Lexington’s Cubist Pharmaceuticals Inc., best-known for its antibiotic Cubicin, will pay up to $1.6 billion to acquire two other drug makers in a bid to increase its line of antibiotics, the company said Tuesday.

The deal to buy Optimer Pharmaceuticals Inc. of Jersey City, N.J., and Trius Therapeutics Inc. of San Diego, Calif., adds an antibacterial drug to the Cubist product portfolio and puts several other antibiotics in its pipeline for approval.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week